Amarin Corporation plc (AMRN)

$10.33

up-down-arrow $0.01 (0.10%)

As on 29-Apr-2025 16:21EDT

Amarin Corporation plc (AMRN) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 10.03 High: 10.43

52 Week Range

Low: 7.08 High: 20.60

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    $232 Mln

  • P/E RatioP/E Ratio information

    --

  • P/B RatioP/B Ratio information

    0.44

  • Industry P/EIndustry P/E information

    --

  • Debt to EquityDebt to Equity information

    0.02

  • ROEROE information

    -0.16 %

  • ROCEROCE information

    -15.58 %

  • Div. YieldDiv. Yield information

    0 %

  • Book ValueBook Value information

    1.18

  • EPSEPS information

    -0.2

10 Years Aggregate

CFO

$-627.25 Mln

EBITDA

$-519.79 Mln

Net Profit

$-640.29 Mln

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Amarin (AMRN)
6.49 17.33 -12.86 -40.96 -42.94 -41.93 -13.00
BSE Sensex
2.61 3.71 5.78 8.89 11.76 20.11 11.35
As on 29-Apr-2025
2024
2023
2022
2021
2020
2019
2018
Amarin (AMRN)
-43.99 -28.10 -64.09 -31.08 -77.19 57.53 237.15
BSE Sensex
8.10 18.74 4.44 21.99 15.75 14.38 5.87
BSE Sensex
8.10 18.74 4.44 21.99 15.75 14.38 5.87

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

Detailed View
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View All
loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer

View All
Company
Price ($) Market Cap ($ Mln) P/E Ratio ROE
38.55 10,593.45 21.84 23.13
306.35 8,570.17 22.78 66.44
27.82 10,589.59 -- -28.77
107.24 10,559.67 32.44 14.16

Shareholding Pattern

Detailed Holdings
loading...
BLAHBLAH

About The Company

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a...  prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland. Address: One Central Plaza, Dublin 2, Ireland, D02 K7K5  Read more

  • President, CEO & Director

    Mr. Patrick J. Holt

  • President, CEO & Director

    Mr. Patrick J. Holt

  • Headquarters

    Dublin 2

  • Website

    https://www.amarincorp.com

Edit peer-selector-edit
loading...
loading...

FAQs for Amarin Corporation plc (AMRN)

The total asset value of Amarin Corporation plc (AMRN) stood at $ 685 Mln as on 31-Dec-24

The share price of Amarin Corporation plc (AMRN) is $10.33 (NASDAQ) as of 29-Apr-2025 16:21 EDT. Amarin Corporation plc (AMRN) has given a return of -42.94% in the last 3 years.

Amarin Corporation plc (AMRN) has a market capitalisation of $ 232 Mln as on 29-Apr-2025. As per Value Research classification, it is a company.

Since, TTM earnings of Amarin Corporation plc (AMRN) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Amarin Corporation plc (AMRN) and enter the required number of quantities and click on buy to purchase the shares of Amarin Corporation plc (AMRN).

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland. Address: One Central Plaza, Dublin 2, Ireland, D02 K7K5

The CEO & director of Mr. Patrick J. Holt. is Amarin Corporation plc (AMRN), and CFO & Sr. VP is Mr. Patrick J. Holt.

There is no promoter pledging in Amarin Corporation plc (AMRN).

Amarin Corporation plc (AMRN) Ratios
Return on equity(%)
-15.83
Operating margin(%)
-37.73
Net Margin(%)
-40.17
Dividend yield(%)
--

No, TTM profit after tax of Amarin Corporation plc (AMRN) was $0 Mln.